Loading...

Bausch Health Companies Inc.

BHCNYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$6.82
$-0.07(-1.02%)

Bausch Health Companies Inc. (BHC) Stock Overview

Explore Bausch Health Companies Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.0/100

Key Financials

Market Cap2.5B
P/E Ratio-58.98
EPS (TTM)$-0.12
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Week$4.60
1 Month$5.98
3 Months$5.23
1 Year Target$6.71

BHC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bausch Health Companies Inc. (BHC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 67.28, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.71.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -58.98 and a market capitalization of 2.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;